Skip to main navigation Skip to search Skip to main content

Immunohistochemical detection of ERβ in breast cancer: Towards more detailed receptor profiling?

  • G. P. Skliris
  • , P. J. Carder
  • , M. R.J. Lansdown
  • , V. Speirs*
  • *Corresponding author for this work
  • University of Leeds
  • St James's University Hospital

Research output: Contribution to journalArticlepeer-review

Abstract

Oestrogen receptor (ER) is used routinely to predict endocrine responsiveness in patients with breast cancer. A second ER, ERβ has been described but its significance remains undefined; most studies have described mRNA levels rather than protein expression. Here, we demonstrate for the first time, immunohistochemical detection of ERβ in archival breast tumours.

Original languageEnglish
Pages (from-to)1095-1098
Number of pages4
JournalBritish Journal of Cancer
Volume84
Issue number8
DOIs
Publication statusPublished - 20 Apr 2001
Externally publishedYes

Funding

We thank Yorkshire Cancer Research and Northern and Yorkshire NHS Executive for financial support. Thanks to Jane Ramsdale for technical assistance.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Breast cancer
  • ERβ
  • Formalin-fixed
  • Immunohistochemistry
  • Paraffin-embedded material

Fingerprint

Dive into the research topics of 'Immunohistochemical detection of ERβ in breast cancer: Towards more detailed receptor profiling?'. Together they form a unique fingerprint.

Cite this